A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther. 2003 Dec; 8(6):507-18.

View in: PubMed

subject areas

Acquired Immunodeficiency Syndrome
Adenine
Adult
Alkynes
Benzoxazines
Cyclopropanes
Dideoxynucleosides
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Genotype
HIV-1
Humans
Indinavir
Male
Nelfinavir
Oxazines
Phenotype
Reverse Transcriptase Inhibitors
Treatment Failure

authors with profiles

Jorge Santana

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support